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Abstract 
Background: Escherichia coli, the gastrointestinal commensal, is also known to cause ocular infections such as con-
junctivitis, keratitis and endophthalmitis. These infections are normally resolved by topical application of an appropri-
ate antibiotic. But, at times these E. coli are resistant to the antibiotic and this could be due to formation of a biofilm. In 
this study ocular E. coli from patients with conjunctivitis, keratitis or endophthalmitis were screened for their antibiotic 
susceptibility and biofilm formation potential. In addition DNA-microarray analysis was done to identify genes that are 
involved in biofilm formation and antibiotic resistance.
Results: Out of 12 ocular E. coli isolated from patients ten isolates were resistant to one or more of the nine antibi-
otics tested and majority of the isolates were positive for biofilm formation. In E. coli L-1216/2010, the best biofilm 
forming isolate, biofilm formation was confirmed by scanning electron microscopy. Confocal laser scanning micro-
scopic studies indicated that the thickness of the biofilm increased up to 72 h of growth. Further, in the biofilm phase, 
E. coli L-1216/2010 was 100 times more resistant to the eight antibiotics tested compared to planktonic phase. DNA 
microarray analysis indicated that in biofilm forming E. coli L-1216/2010 genes encoding biofilm formation such as cell 
adhesion genes, LPS production genes, genes required for biofilm architecture and extracellular matrix remodeling 
and genes encoding for proteins that are integral to the cell membrane and those that influence antigen presenta-
tion are up regulated during biofilm formation. In addition genes that confer antimicrobial resistance such as genes 
encoding antimicrobial efflux (mdtM and cycA), virulence (insQ, yjgK), toxin production (sat, yjgK, chpS, chpB and ygjN), 
transport of amino-acids and other metabolites (cbrB, cbrC, hisI and mglB) are also up regulated. These genes could 
serve as potential targets for developing strategies for hacking biofilms and overcoming antibiotic resistance.
Conclusions: This is the first study on global gene expression in antibiotic resistant ocular E. coli with a potential to 
form biofilm. Using native ocular isolates for antibiotic susceptibility testing, for biofilm formation and global gene 
expression is relevant and more acceptable than using type strains or non clinical strains which do not necessarily 
mimic the native isolate.
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Background
Escherichia coli, is a coliform bacterium that occurs as a 
commensal in the gut of humans and other warm blooded 
mammals [1] and exhibits high degree of genotypic and 
phenotypic diversity. A few of them are pathogenic [2, 3] 
and include the verotoxigenic (VTEC), entero-haemor-
rhagic (EHEC, a subclass of the VTEC class), entero-inva-
sive (EIEC) and uro-pathogenic/extra-intestinal pathogenic 
(UPEC/ExPEC) classes and are harmful to their hosts [3, 
4]. E. coli also inhabits different environmental niches viz., 
soil, water, sediment, food, abiotic and biotic surfaces [5] 
like the surface of the eye and the inner surface of the eye 
lids. But, E. coli is not the only bacterium on the ocular 
surface and includes several other Gram-negative bacteria 
(Neisseria spp., Pseudomonas aeruginosa and Haemophilus 
influenzae) [6, 7], Gram-positive bacteria (Staphylococcus 
epidermidis, S. aureus, Corynebacterium spp., Streptococci 
spp., and Propionibacterium acnes), fungi (Fusarium solani, 
Cladosporium sphaerospermum, Acremonium implica-
tum, Candida albicans and Aspergillus fumigatus) [8–10] 
and viruses. More recently using non-cultivable molecular 
techniques based on 16S rRNA gene sequencing a greater 
bacterial diversity has been observed associated with the 
eye [11–14]. In all these studies the diversity of bacteria 
was very different and genera Staphylococcus, Corynebac-
terium, Propionibacterium and Streptococcus were the only 
common genera. Thus based on these studies it is difficult 
to conclude as to what constitutes the ocular surface micro-
biota (or a core microbiome) or whether the microbiota are 
only transiently present [15].
Characterising the ocular microbiome is important 
because following trauma or under immuno-compro-
mised conditions these ocular microbiota may cause 
infection of the eye (such as keratitis, endophthalmitis, 
orbital cellulitis etc.) often leading to loss of vision. But, 
ocular infections such as conjunctivitits and keratitis may 
also originate from dirty fingers and contaminated con-
tact lenses. Normally the infection is resolved following 
treatment with antifungal/antibacterial agents. However, 
over the years many of these organisms have become 
resistant to drugs. In preliminary studies carried out at 
the Jhaveri microbiology centre at L V Prasad Eye Insti-
tute (a tertiary eye care center), Hyderabad, India, several 
corneal pathogens were observed to be tolerant to one or 
more ocular antibiotics thus implying the emergence of 
tolerant strains [16]. Resistance to drugs may be linked to 
biofilm formation. Bacteria in a biofilm exhibit increased 
resistance to antibiotics due to binding of the antibiot-
ics to the extracellular polymeric substances (EPS), due 
to production of enzymes that inactivate antibiotics, due 
to nutrient and oxygen limitation, due to increase in the 
efficiency of efflux pumps and due to up regulation of 
drug resistance-associated genes [17, 18].
Bacteria have been reported to form biofilm on contact 
lenses, intraocular lenses, lid implants, orbit implants, 
socket implants, scleral buckles and suture material [19, 
20]. P. aeruginosa, S. epidermidis, Streptococcus spp. 
and Enterobacter have been identified to be a part of the 
biofilm [18]. Katiyar et  al. [21] demonstrated that 85% 
of the isolates from intraocular lenses represented by P. 
aeruginosa, Staphylococcus aureus, S. epidermidis, Mic-
rococcus luteus, S. marcescens, Neisseria spp., Moraxella 
spp., Bacillus spp., E. coli, Proteus mirabilis, Enterobacter 
agglomerans and Klebsiella spp., exhibited the potential 
to form biofilms and were resistant to antibiotics.
Information on genes that are differentially regulated 
during biofilm formation and correlating the results to 
increased resistance to antimicrobials have not been 
studied in ocular bacteria. With this in view, in the pre-
sent study ocular isolates of E. coli which are known to 
cause about 1.1% of the total ocular infections [22] such 
as keratitis [23], endophthalmitis [24, 25], conjunctivitis 
[6], pan-ophthalmitis [26] and eyelid abscess [27], were 
used as model systems to investigate antibiotic suscepti-
bility and biofilm formation potential. In addition global 
gene expression was studied by DNA-microarray analy-
sis to identify genes that are involved in biofilm forma-
tion and antibiotic resistance. This approach using the 
native ocular isolates for global gene expression is rel-
evant considering that studies have indicated that use 
of type strains (or non clinical strains) may not be the 
right approach to understand antibiotic resistance in a 
biofilm forming microorganism [28, 29]. Since the type 
strains of the same species need not necessarily mimic 
exactly the native isolate. The results of this study would 
unravel the identity of genes that are differentially regu-
lated during biofilm formation and identify differen-
tially regulated genes related to increased resistance to 
antimicrobials.
Methods
Collection of samples and bacterial identification
The Jhaveri Microbiology Centre of the Prof. Brien 
Holden Eye Research Centre at the L V Prasad Eye Insti-
tute, Hyderabad, India receives over 4000 clinical samples 
per annum from patients with eye infections. These sam-
ples are processed for the detection of bacteria and fungi 
and subsequently the cultures are purified, identified 
and preserved in tryptone soya broth with 30% glycerol 
at −80  °C. This study used 12 E. coli isolates preserved 
between 2010 and 2014. All preserved isolates of bacteria 
were cultured on 5% sheep blood agar medium at 37 °C. 
A pure homogenous culture obtained after repeated 
streaking was then subjected to Vitek 2 compact (bioMé-
rieux, France) analysis for identification of the bacterium. 
Tests were performed according to the manufacturer’s 
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instructions and the cultures were identified with the 
database of the instrument.
Biofilm detection
The potential to form a biofilm was assessed in 12 ocular 
isolates of E. coli using the microtiter/tissue culture plate 
(TCP) method [30]. In the TCP or crystal violet method 
a single colony of the bacterium was inoculated into 
5 ml medium of brain–heart infusion (BHI) and tryptic 
soy broth (TSB) (HiMedia Laboratories, Secunderabad, 
India) separately and incubated overnight. The culture 
was then adjusted to 0.5 McFarland units, diluted 100-
fold and 100  µl of the diluted inoculum was dispensed 
into a single well of a 96 well plate (Thermo Fisher Sci-
entific, Nunclon™, Denmark) containing 100  µl of fresh 
medium. The plate was then incubated at 37 °C for 72 h. 
The broth was then discarded by inverting the plate 
and gently tapping it after which it was washed thrice 
with 200  µl of phosphate buffered saline (PBS, Sigma-
Aldrich Corporation, St. Louis, MO, USA) and allowed 
to dry for 30 min. The bacteria in the biofilm adhering to 
the plate were then stained with 200  µl of 0.1% Crystal 
violet for 30  min and the Crystal violet associated with 
the cells was then extracted with 200  µl of ethanol and 
quantified spectrophotometrically at 595 nm [30]. Visu-
ally, wells without the inoculum (control) and wells with 
bacteria that did not possess the potential to form biofilm 
were white to pale blue in colour. But, wells inoculated 
with bacteria which have a potential to form a biofilm are 
moderate to dark blue in colour indicative of biofilm for-
mation. Wells without cells inoculated served as the con-
trol and the OD was <0.1 at 595  nm and was deducted 
from the biofilm positive strains (OD  >  0.3 at 595  nm) 
and the biofilm negative strains (OD < 0.3 at 595 nm).
The TCP method was used to ascertain the optimum 
temperature and pH required for biofilm formation using 
two different media. The 12 ocular E. coli isolates were 
either incubated at 30 or 37 °C in BHI or TSB and the pH 
of the medium was adjusted to 5, 6, 7, 8 or 9 and incu-
bated for 72 h. Following crystal violet staining the bio-
film was quantified as above by recording the absorbance 
at 595 nm.
Visualization of biofilm by scanning‑electron microscopy 
(SEM) and confocal laser scanning microscope (CLSM)
A single colony of E. coli L-1216/2010 was incubated 
overnight at 37  °C in BHI or TSB. The culture was then 
adjusted to 3 McFarland with the medium and then 20 µl 
of 3 McFarland culture was made up to 200  µl using 
the same medium and transferred on to a sterile glass 
cover slip (10 × 10 mm) and placed in the 12 well plate 
(Thermo Fisher Scientific, Nunclon™, Denmark) and 
incubated for different time intervals (24, 48 and 72 h.) at 
37 °C. After incubation, the adhering biofilm was washed, 
fixed with 2.5% glutaraldehyde solution for 2  h, washed 
thrice with distilled water and dehydrated through a 
graded series of ethanol (10, 25, 50, 70, 90, and 100%) for 
20 min in each grade. Finally, the biofilms were air dried 
at 37 ± 1 °C for 24 h. Prior to visualisation of the biofilm 
using a SEM (HITACHI-Model S-3400N, Japan) the bio-
films were metalized by gold sputtering for 45 s in a High 
Vacuum Evaporator (SC7620 PALARON Sputter Coater).
Escherichia coli biofilms of strain L-1216/2010 were 
also visualized by CLSM. The biofilms were grown for 
24, 48 and 72 h as above, washed twice gently with auto-
claved water and the adhering biofilm fixed with 4% for-
maldehyde (Himedia-Secunderabad, India) for 45  min. 
The fixed biofilms were then washed twice with auto-
claved water and stained with 200 µl of 1.67 µM  Syto®9 
nuclear fluorescent dye (Thermo Fisher Scientific, USA) 
for 30 min. The stained biofilms were washed again with 
autoclaved water and mounted on a glass slide using 
mounting media (Thermo Fisher Scientific, USA). Con-
focal images were taken using Zeiss confocal laser scan-
ning microscope (LSM 510). Argon Laser was excited at 
450–490 nm, a 40× objective was used set at Zoom 2.
Antibiotic susceptibility of ocular E. coli
The susceptibility of the 12 clinical isolates of E. coli to 
different antibiotics as listed in Table  1 was determined 
on Mueller Hinton agar medium (MHA-Himedia) by 
Kirby Bauer disc diffusion method as per CLSI 2012 
guidelines [31] to determine the susceptibility of the iso-
lates to different antibiotics. In addition the minimum 
inhibitory concentration (MIC) of the antibiotic required 
to inhibit the growth of the 12 isolates was determined 
by the micro-dilution method. For this purpose, over-
night grown culture from the BHI medium was adjusted 
to 0.5 McFarland and 200  µl was transferred into each 
well of the 96 well plate and incubated at 37 °C for 16 h 
as described by The European Committee on Antimicro-
bial Susceptibility Testing (EUCAST) in 2003 [32] in the 
presence of the antibiotic. At the end of the incubation 
period OD 595 nm was determined. Each antimicrobial 
concentration was tested thrice and the mean values 
are presented. All the antibiotics were obtained from 
commercial sources. The susceptibility of E. coli isolate 
L-1216/2010 was also determined after the formation of 
the biofilm. In this experiment, overnight grown culture 
from then BHI medium was adjusted to 0.5 McFarland 
and 200 µl was transferred into each well of the 96 well 
plate and incubated at 37 °C for 48 h for biofilm forma-
tion. Planktonic cells were discarded, bound cells washed 
with milliQ water and then the antibiotic (dissolved in 
BHI medium) of a specific concentration was added to 
the biofilm and incubated for 16 h. The capability of the 
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bacterium to form biofilm was monitored in the absence 
and the presence of different antibiotics at different con-
centrations by the crystal violet method. The concentra-
tion of the antibiotic that inhibited the formation of the 
biofilm was determined. E. coli isolate L-1216/2010 in 
the planktonic phase (where in antibiotics were added 
after 24  h of growth) and non-biofilm forming E. coli 
(L-1339/2013) were used as controls for this experiment.
DNA microarray analysis
RNA was extracted from biofilm cells and non-biofilm 
cells incubated for 72 h at 37 °C in BHI broth. For biofilm 
cells, E. coli (L-1216/2010) cells were allowed to grow and 
attach to plastic petri plates for 72 h (100 mm diameter 
containing 15  ml medium). After 72  h the planktonic 
cells were removed and only cells that were attached to 
the petri plate were considered as the biofilm cells and 
scrapped from the petriplate and were collected in a Fal-
con tube. The non-biofilm E. coli L-1339/2013 was used 
as the control. Cells of E. coli L-1339/2013 were allowed 
to grow for 72 h, centrifuged at 10,000 rpm in a micro-
centifuge (Eppendorf, New York, USA) and the pellet was 
collected. The pellets of the biofilm cells and non-biofilm 
cells were suspended separately in 1 ml of ice cold phos-
phate buffer (pH 7.2) to which 3 ml of RNAlater® (Inv-
itrogen BioServices India Pvt. Ltd, Bangalore 560 066, 
India) was added and the suspensions incubated for 
30 min. Collection of cells to the addition of RNAlater® 
was completed within 15  min. Extraction of total RNA, 
cDNA synthesis and DNA microarray analysis of all the 
six samples was done as described in our previous paper 
[33]. Briefly for this, the total RNA from the samples 
was extracted using Qiagen RNeasy mini-prep kit. This 
is followed by cDNA synthesis from the RNA (6  μg) by 
reverse transcription process using the first strand cDNA 
synthesis kit (Invitrogen Bioservices India Pvt. Ltd., Ban-
galore). Then the cDNA was fragmented with DNAse 1 
(Promega Corporation, Madison, USA) and then labelled 
with biotin at the 3′ end using the labelling reagent from 
Affymetrix (CA, USA) and Terminal transferase enzyme 
(Promega). E. coli Genome 2.0 gene chip arrays were 
used for the DNA microarray study (Affymetrix CA, 
USA). The chip contained the complete genome of four 
E. coli strains (viz., non-pathogenic E. coli K12 MG1655, 
uropathogenic E. coli strain CFT073 and enterohemor-
rhagic E. coli O157:H7 strains EDL 933 and Sakai). The 
gene chip consists of approximately 10,000 probe sets for 
the 20,366 genes of all the four strains of E. coli. Three 
biological replicates were used for each condition of the 
experiment. The fragmented and labeled cDNA of E. coli 
cells from each biological replicate were processed inde-
pendently and hybridized with DNA microarray chip. 
Thus for each condition of the experiment three DNA 
microarray chips were used. Microarray chips were then 
scanned using Affymetrix 428 Array Scanner and GCOS 
software to obtain images of the chips and further pro-
cessed to get the florescent intensity of the probe sets. 
The fluorescent intensities were generated for the hybrid-
ized probes for each of the DNA microarray chips sepa-
rately and analysed. The fluorescent intensity images 
were then normalized for background correction and 
data was analyzed using Gene Spring 12.5 software. To 
Table 1 Resistance profile of 12 ocular E. coli to nine antibiotics by the Kirby–Bauer disc diffusion method and their bio-
film forming potential by and the tissue culture plate (TCP) method
The antibiotics used are (µg/disc): Am amikacin (30), Ce ceftazidime (30), Cef cefuroxime (30), Ch chloramphenicol (30), Ci ciprofloxacin (5), Ga gatifloxacin (5), Ge 
gentamicin (10), Mo moxifloxacin (5) and Of ofloxacin (5)
+, biofilm positive strains (black colonies); −, biofilm negative strains (red or pink colonies). biofilm positive strains (OD > 0.3 at 595 nm); −, biofilm negative strains 
(OD < 0.3) at 595 nm. The OD of the control wells was deducted in each case
S. no E. coli strain Ocular sample Patient diagnosis Resistance to antibiotics (µg/disc) Biofilm production 
by TCP method ±
1 L-1339/2013 Conjunctival swab Conjunctivitis Ce, Cef, Ci, Ga, Ge, Mo, Of −
2 L-1216/2010 Vitreous Endophthalmitis Ci +
3 L-2561/2013 Vitreous Endophthalmitis None +
4 L-1920/2011 Corneal scraping Keratitis Am, Ce, Cef, Ch, Ci, Ga, Ge, Mo, Of +
5 L-3781/2010 Vitreous Endophthalmitis Ce +
6 L-3484/2010 Vitreous Endophthalmitis None −
7 L-1573/2013 Vitreous Endophthalmitis Ci, Mo, Of +
8 L-494/2011 Vitreous Endophthalmitis Am, Ce, Cef, Ci, Ga, Ge, Mo, Of +
9 L-223/2014 Corneal scraping Keratitis Ce, Cef, Ci, Ga, Mo, Of +
10 L-304/2014 Corneal scraping Keratitis Ce, Cef +
11 L-811/2014 Lacrimal sac Dacryocystitis Ce, Cef, Ci, Ga, Ge, Mo, Of +
12 L-823/2014 Corneal scraping Keratitis Cef +
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identify the significantly differentially regulated genes 
we have normalized the data of all biological replicates of 
both biofilm and non-biofilm E. coli cells by using PLIER 
(probe logarithmic intensity error estimation) followed 
by statistical analysis such as unpaired T test and P value 
calculation. Genes that exhibited ≥2.0-fold increase 
or decrease (biofilm cells versus non-biofilm cells) in 
expression and P ≤0.05 were considered as significantly 
differentially regulated genes. The microarray data was 
submitted to Gene Expression Omnibus (GEO) web 
deposit of National Centre for Biotechnology Informa-
tion (NCBI, Maryland, USA) with an accession number 
GSE77872.
Annotation of the genes
The differentially regulated genes were classified based 
on their function using Clusters of Orthologous Groups 
(COG), a software annotation pipeline associated with 
the Prokaryotic Genome Analysis Tool (PGAT) [34]. The 
COG protein database was generated by comparing pre-
dicted and known proteins in all completely sequenced 
microbial genomes to infer sets of orthologs. Various sets 
of differentially expressed genes based on their function-
ality were analysed for their interactions using GeneMA-
NIA cytoscape plugin network analysis web tool [35]. 
Using GeneMANIA we performed all the possible default 
network interactions available for E. coli viz., co-expres-
sion, genetic interactions, protein interactions and other 
interactions. When the gene list exceeded more than 100 
Cytoscape plugin was employed to derive the networks.
Validation of microarray data by real time PCR (RT‑PCR)
Expression of the genes ydcT, ECS1633, yjcQ, ompC, 
perM, waaL, focA, fliC and oprR was validated by RT-
PCR following the protocol described in our previous 
paper [33]. The RT-PCR reactions were performed in 
triplicate. Relative expression of genes was calculated by 
ΔΔCT method. Expression of 16S rRNA gene was used 
as an internal standard. All values reported represent the 
mean of three independent experiments.
Results
Ocular isolates of E. coli and antibiotic susceptibility
Twelve E. coli isolates used in this study were isolated 
from keratitis (corneal scrapings), conjunctivitis (con-
junctival swabs), endophthalmitis (vitreous fluid) or 
dacryocystitis (lacrimal sac pus) patients visiting the L. V. 
Prasad Eye Institute (LVPEI), Hyderabad, India, between 
the year 2010 and 2014 (Table 1; Additional file 1: Table 
S1). The demographic profile of the patients along with 
some clinical details is shown in the Additional file  1: 
Table S1. The patients were diagnosed and treated as per 
the institutional protocol. Visual acuity at presentation 
and at last follow up is also given in the Additional file 1: 
Table S1.
The antibiotic susceptibility results of the 12 ocular E. 
coli isolates (Table  1) indicated that except two isolates 
(L-3484/2010 and L-2561/2013) from the vitreous which 
were susceptible to all the antibiotics tested the remain-
ing ten isolates were resistant to at least one or more 
antibiotics. Isolate (L-1920/2011) from corneal scrap-
ings was the only isolate that showed resistance to all the 
antibiotics.
Biofilm potential of ocular isolates of E. coli
In the microtiter/tissue culture plate (TCP) method ten 
isolates were positive for biofilm formation and showed 
an OD >0.3 at 595 nm compared to the negative strains 
whose OD was consistently <0.3 at 595  nm (Table  1; 
Additional file 2: Figure S1). The best biofilm forming iso-
late L-1216/2010 by the TCP method had an OD of 3.4 
after 72 h of growth. The optimum conditions for biofilm 
formation as determined by the TCP method for all the 
isolates was 37 °C at pH 7.3 when grown on BHI or TSB 
medium and incubated for 72 h. Growth and biofilm for-
mation in E. coli strains was repeated three times under 
optimum conditions. All future experiments related to 
antibiotic susceptibility of the biofilm and the genes that 
are differentially regulated were done with L-1216/2010 
which formed a biofilm and L-1339/2013 which did not 
form a biofilm as the control under the above optimum 
conditions.
Biofilm of ocular E. coli L-1216/2010 was also visual-
ised by scanning electron microscopy (HITACHI-Model 
S-3400  N, Japan) (Fig.  1a–c). The scanning electronic 
microscopic images revealed that at 24  h cells were 
attached to the substratum and were evenly spread and 
the morphology of the cells was discernible. By 48 h the 
cells were entangled in the EPS and by 72 h a luxuriant 
biofilm was formed and the cells were totally covered 
within the biofilm and individual cells were not clearly 
visible. Biofilm formation in ocular E. coli L-1216/2010 
was also confirmed by using a Zeiss confocal laser 
scanning microscope. The results clearly indicated an 
increase in the thickness of the biofilm with growth. The 
biofilm increased in thickness from 5.30 μm after 24 h to 
15.01 μm at 72 h of growth (Fig. 1d–f).
The antibiotic susceptibility of biofilm of ocular E. coli 
L-1216/2010 was determined after allowing the cells 
to form a biofilm for 48 h. Three biological replicates of 
ocular E. coli L-1216/2010 were used for this process. The 
results indicated that E. coli L-1216/2010 in the biofilm 
phase required >5 mg/ml antibiotic to exhibit total sus-
ceptibility to the tested antibiotics where as planktonic 
cells of E. coli 1216/2010 (Fig. 1h) and E. coli L-1339/2013 
(Fig.  1i) and the remaining ten strains of ocular E. coli 
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were less tolerant and exhibited no growth at concentra-
tions ranging from 0.005 to >0.064 mg/ml depending on 
the antibiotic tested (Fig. 1g–i; Table 2).
Expression of genes in E. coli biofilm forming cells
Analysis of the microarray data indicated that in the bio-
film forming ocular E. coli (L-1216/2010) cells after 72 h 
of biofilm formation, hundreds of genes were significantly 
differentially expressed with a fold change >2 (P < 0.05) 
compared to the non biofilm cells of E. coli L-1339/2013 
(Fig.  2a). It was noted that 1292 (426 up and 866 down 
regulated) genes were significantly differentially regu-
lated in the biofilm forming E. coli (L-1216/2010) cells 
compared to the non-biofilm forming E. coli L-1339/2013 
cells. The cluster analysis (Fig. 2b) and heat maps (Fig. 2c) 
of the microarray data generated using mRNA of three 
biological replicates of biofilm cells of E. coli L-1339/2013 
(BF1, BF2, BF3) and non biofilm forming cells from three 
biological replicates of E. coli L-1339/2013 (N1, N2, N3) 
also clearly showed that the biofilm cells were differ-
ent from the non-biofilm cells (Fig. 2b, c). The Principal 
Component analysis also confirmed that the biofilm cells 
are more closely related and are less related to the non-
biofilm cells (Fig. 2d).
Functional annotation of differentially expressed genes 
in E. coli biofilm forming cells
Functional annotations and cluster categorization of the 
genes was done using DAVID, KEGG and COG analy-
sis [33, 34]. Genes that could not be annotated and the 
duplicate genes were removed from the differentially 
expressed gene list of microarray data. This resulted in 
differential expression of a total of 1060 (385 upregu-
lated and 675 downregulated) genes (Additional file  3: 
Table S2, Additional file 4: Table S3). Using COG all the 
genes could be categorized into four main categories 
viz., cellular processes and signaling, information stor-
age and processing, metabolism and poorly characterized 
or unknown genes (Table  3). Each category included a 
number of sub-categories and the differentially regulated 
genes (up and down regulated) were compared at the 
sub-category level with data obtained in this study and 
three earlier studies (Table 3).
(See figure on previous page.) 
Fig. 1 Biofilm forming potential in ocular E. coli L-1216/2010 as monitored by scanning electron microscopy after 24 (a), 48 (b) and 72 (c) h of 
biofilm growth and by confocal scanning laser microscopy after 24 (d), 48 (e) and 72 (f) h of biofilm growth. In d–f, the biofilm was stained with 
Syto9. The Z axis indicates the thickness of the biofilm which is 5.30, 8.10 and 15.01 μm after 24, 48 and 72 h of biofilm growth. g Represents the 
susceptibility of ocular E. coli L-1216/2010 in the biofilm phase, h represents the susceptibility of ocular E. coli L-1216/2010 in the planktonic phase 
and i represents the susceptibility of non-biofilm forming E. coli L-1339/2013 to different concentrations of antibiotics
Table 2 Minimum inhibitory concentrations of antibiotics against 12 ocular E. coli isolates
E. coli strain Sample Amikacin Ceftazidime Cefuroxime Chloram‑
phenicol




12 24 48 16 12 32 24 32
L-1216/2013 Vitreous 16 12 28 20 12 12 16 16
L-2561/2013 Vitreous 6 2 4 4 0.5 2 12 1
L-1920/2011 Corneal scrap-
ing
64 16 32 32 12 16 8 12
L-3781/2010 Vitreous 12 16 8 6 0.5 2 16 16
L-3484/2010 Vitreous 12 2 4 6 1 2 8 2
L-1573/2010 Vitreous 6 4 8 4 4 4 8 1
L-494/2011 Vitreous 64 16 32 6 8 16 12 12
L-223/2014 Corneal scrap-
ing
12 24 48 8 4 4 16 32
L-304/2014 Corneal scrap-
ing
6 24 32 6 0.5 2 8 1
L-811/2014 Lacrimal sac 6 16 32 4 4 32 12 32
L-823/2014 Corneal scrap-
ing
6 2 24 2 0.5 4 6 1
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Validation of DNA microarray results
Expression of few of the genes that were differentially 
regulated in the sessile biofilm cells was validated by RT-
PCR. In accordance with DNA microarray results genes 
ydcT, ECS1633, yjcQ, ompC, perM and waaL showed 
increased expression (P < 0.05) whereas genes focA, fliC 
and oprR showed decreased expression (P  <  0.05) in E. 
coli (L-1216/2010) with potential to form biofilm com-
pared with E. coli (L-1339/2013) that does not form a 
biofilm (Fig. 3a, b).
Genemania network analysis
Following functional annotation and cluster categori-
zation of the up regulated genes using DAVID, the up 
regulated genes in biofilm forming E. coli (L-1216/2010) 
cells were networked using GeneMANIA. GeneMA-
NIA deduces networks by integrating publicly avail-
able genomic and proteomic data of 33 previous studies. 
GeneMANIA network analysis predicts that cell adhe-
sion genes (fimA, yadK, yadN, yadM and yadC) were 
co-expressed along with genes encoding drug transport 
(mdtM and cycA), aldonate transport (yjjL), transporter 
activity (htrE), active transmembrane transporter activ-
ity (potG, mngA) and gluconate transport (gntP) (Fig. 4a). 
Network analysis also revealed that emrB interacts with 
proteins encoded by mdtM and mdfA involved in multi-
drug resistance (Fig. 4a) thus accounting for the observed 
up regulation of mdlA and mdtM. Gene emrB also shared 
genetic interaction with several genes involved in aldo-
nate and gluconate transport (Fig.  4a). Up regulated 
Fig. 2 Differential gene expression in f E. coli (L-1216/2010) with potential to form biofilm versus non-biofilm forming cells of E. coli (L-1339/2013) 
grown for 72 h. In a, in the volcano plots genes that are represented on the right side of the volcano-axis are up regulated and those that are 
on left side of the axis are down regulated. In b, cluster analysis of biofilm forming E. coli (L-1216/2010) with non-biofilm forming cells of E. coli 
(L-1339/2013). In c, heat map analysis shows that the biofilm cells (BF1–BF3) are less related to non-biofilm cells (N1–N3) of E. coli. Principal compo-
nent analysis (d)
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genes in the biofilm forming cells belonging to lipopoly-
saccharide biosynthetic process (viz., waaJ, waaP, waaU 
and waaB) were co-expressed in the network analysis 
(Fig. 4b). Network analysis also indicated that several of 
the genes integral to cell membrane (yiiX, cbrB, cbrC, 
hisI) interact with one another (Additional file 5: Figure 
S2) and with genes encoding for putative fimbriae like 
proteins (yadC, yadL and yadM), outer membrane pro-
teins (htrE), transcriptional regulators (mngR, nhaR), 
DNAdamage repair proteins (uvrD), cytosine deaminase 
(codA) and other genes. Network analysis also indicated 
that the hypothetical genes are interlinked to ABC trans-
port protein genes, DNA replication, rrna genes and 
outer membrane genes and may thus be functionally use-
ful for biofilm formation and virulence characteristic of 
the bacterium (Additional file 6: Figure S3).
Discussion
Our results indicate that 10 out of the 12 ocular E. coli 
isolates from conjunctival swab, corneal scrapings, vit-
reous fluid or lacrimal sac of patients were resistant to 
at least one or more of the nine antibiotics tested. Out 
of these ten antibiotic tolerant ocular E. coli, major-
ity of the isolates (8/10) were positive for biofilm for-
mation by the TCP method thus implying a close 
association between antibiotic tolerance and biofilm 
formation [36, 37]. Surprisingly we also observed that E. 
coli L-2561/2013 from the vitreous fluid of Endophthal-
mitis patients was not resistant to any one of the anti-
biotics tested but possessed the ability to form biofilm. 
This is indeed interesting. A recent study also indicated 
that biofilm formation was independent of antibiotic 
resistance. For instance in Acinetobacter baumannii out 
Table 3 Comparison of the differentially regulated genes in this study and three earlier studies based on COG sub-cate-
gories
The figures in each column indicate the number of genes up or down regulated in each category. Comparison between the four studies in terms of genes up or down 
regulated are not anticipated to be identical but the trends may be similar. For instance the number of genes up or down regulated when ABU E. coli is compared with 
ocular E. coli is similar for category V, L, F and I. Such comparisons could also be done between ocular E. coli and the other two strains of E. coli
Functional group classification based on COG Beloin et al. [40] Domka et al. [42] Hancock et al. 
[43]
This study
E. coli strain E. coli K‑12 E. coli K‑12 ABU E. coli Ocular E. coli
Regulation Up Down Up Down Up Down Up Down
Cellular processes and signaling
 M. Cell wall/membrane/envelope biogenesis 19 9 9 8 4 25 14 14
 D. Cell cycle control, mitosis and meiosis 2 1 0 0 3 6 14 14
 N. Cell motility NA NA 32 1 1 0 7 19
 O. Post-translational modification, protein turnover, and chaperones 13 13 13 7 25 56 8 11
 T. Signal transduction mechanisms 5 0 11 3 12 2 7 5
 U. Intracellular trafficking, secretion, and vesicular transport NA NA 28 1 2 17 8 19
 V. Defense mechanisms NA NA 4 0 1 0 1 0
 Sub-total 39 23 97 20 48 106 59 82
Information storage and processing
 A. Transcription, RNA processing and modification 11 5 17 7 44 8 12 6
 L. Replication, recombination and repair 10 7 5 1 17 14 16 10
 Sub-total 21 12 22 8 61 22 28 16
Metabolism
 C. Energy production and conversation 23 9 23 16 12 34 12 18
 E. Amino acid transport and metabolism 9 22 20 15 5 36 20 17
 F. Nucleotide transport and metabolism 0 3 8 1 6 8 5 5
 G. Carbohydrate transport and metabolism 16 22 27 5 13 23 26 12
 H. Coenzyme transport and metabolism 3 5 6 1 9 14 5 7
 I. Lipid transport and metabolism 7 0 5 3 3 8 2 5
 P. Inorganic ion transport and metabolism 12 6 24 9 14 7 4 8
 Q. Secondary metabolites biosynthesis, transport and catabolism 2 1 5 0 2 7 5 2
 Sub-total 72 68 118 50 64 137 79 74
Unknown and general prediction only 121 86 53 6 57 23 24 29
Total 253 189 290 84 230 288 190 201
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of 63 strong biofilm makers 79.4% were non-multidrug-
resistant strains and the authors observed a negative 
correlation between antibiotic resistance and biofilm 
forming capacity [38]. This observation was interpreted 
as indicating that biofilm improves the survival of bac-
teria in which resistance is low [38]. The study also indi-
cated that ocular E. coli L-1216/2010, required >5  mg 
antibiotic for total susceptibility in the biofilm phase 
compared to microgram quantities that were required 
to inhibit the growth in the planktonic phase thus 
implying 100-fold increase in resistance in the biofilm 
phase. These observations confirm an earlier study in 
Pseudomonas aeruginosa, E. coli, coagulase-negative 
Staphylococcus etc. which had also indicated increased 
resistance to antibiotics in biofilm phase versus plank-
tonic phase. This is the first study on antibiotic suscepti-
bility of an ocular isolate of E coli in the biofilm phase to 
different antibiotics.
Differential gene expression in both pathogenic and 
non-pathogenic E. coli with the ability to form biofilm has 
been studied earlier (E. coli K12 and ABU E. coli) using 
various platforms and the results indicated that several 
genes were differentially regulated and the number var-
ied from 233 to 815 genes representing about 5.4–19.07% 
of the total genes [39–43]. The primary aim of this study 
was to identify genes that are differentially expressed 
during biofilm formation and also demonstrate that dur-
ing biofilm formation the genes that facilitate drug resist-
ance are up regulated. Therefore we chose L-1216/2010 
to represent biofilm forming E. coli since it was the best 
biofilm forming isolate and resistant to just only one anti-
biotic and as a control we chose L-1399/2013 which was 
resistant to seven antibiotics and did not form a biofilm. 
This approach would allow us to identify genes which are 
up-regulated and associated with biofilm formation and 
also genes which are involved in drug resistance over and 
above the drug resistant E. coli L-1399/2013 which does 
not form a biofilm.
In the present study, we observed that in biofilm form-
ing ocular E. coli L-1216/2010 the number of genes that 
were significantly differentially regulated during bio-
film phase were higher (385 and 675 genes respectively 
were up and down regulated) compared to the previ-
ous studies. Comparison of the differentially regulated 
genes in ocular E. coli with that of E. coli K12 and ABU 
E. coli revealed that differential regulation of genes of 
the sub-category U (intracellular trafficking, secretion, 
and vesicular transport), V (defence mechanisms) and L 
(Replication, recombination and repair) were similar in 
pathogenic ABU E. coli and ocular E. coli (Table 3). Fur-
ther, ocular E. coli could be differentiated from E. coli 
K12, a laboratory strain, with respect to regulation of 
genes belonging to the sub-categories D (cell cycle con-
trol, mitosis and meiosis), N (cell motility), U (intracel-
lular trafficking, secretion and vesicular transport) and V 
(defense mechanisms) (Table  3). In the subsequent part 
genes relevant to biofilm and virulence in antibiotic tol-
erant ocular E. coli L-1216/2010 would be discussed in 
comparison with the previously published data on non-
pathogenic E. coli K12 and pathogenic ABU and uropath-
ogenic E. coli.
Genes involved in motility and adhesion
In motile E. coli, biofilm formation is correlated with 
its ability to swim [44, 45]. Thus it is not surprising that 
genes coding for a second flagellar system fhiA [46], 
minor tail protein ECs1554, fimA coding for type 1 fim-
briae [39–41], yadL and yadM [47], Z5029 and Z1651 
coding for putative fimbrial-like adhesin proteins are up 
regulated in biofilm forming ocular E. coli L-1216/2010. 
Among these genes fhiA and ECs1554 are shown to be 
associated with biofilm formation in K-12 strains of 
E. coli [48, 49] and in one of the ABU strains VR50 [43]. 
But fim genes were not up regulated in expression in 
ABU strain 83972 [43] and in UPEC strain CFT073 [39]. 
Fig. 3 Real-time PCR validation of the expression of genes in biofilm 
(closed box) and non-biofilm cells (hatched box) of E. coli (L-1216/2010) 
and E. coli (L-1339/2013) (open box) respectively. a Relative expression 
of up-regulated genes and b Relative expression of down-regulated 
gene
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Fig. 4 GeneMANIA network analysis of cell adhesion and transport genes. a Represents the interaction of genes at nodes encoding for transport 
activity with the cell adhesion genes. b Represents interaction of genes encoding for lipopolysaccharide
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Thus expression of genes encoding fimbriae and fimbriae 
related functions in E. coli appear to be strain-specific 
[50]. GeneMANIA network analysis also predicted a co-
expression network interaction of fimA with that of fim-
brial adhesion protein encoding genes yadL and yadM. 
Gene bdcA, a c-di-GMP-binding biofilm dispersal media-
tor protein was also up regulated in E. coli L-1216/2010 
and co-expressed with genes encoding for cell adhesion 
(Fig.  4a). Several small molecules like Cyclic di-GMP 
(c-di-GMP) [51], acetyl phosphate (AcP) [52] and ppGpp 
promote biofilm formation. Biofilm formation in Gram 
negative bacterial cells is also facilitated by the adhe-
sion of cells to the substratum which is conferred by the 
lipopolysaccharide (LPS) of the outer membrane [53]. In 
this study it is observed that genes coding for both the 
major components of LPS, namely hydrophobic lipid A 
moiety (waaB, waaP, waaJ and waaR) and the phospho-
rylated core oligosaccharide (waaU and waaY) and those 
coding for the O antigen synthesis (waaL and wzzB) 
are up regulated. However, in contrast in pathogenic 
ABU strains of E. coli, genes encoding lipid A remain 
unchanged and genes involved in peptidoglycan biosyn-
thesis were down-regulated [43]. LPS, in E. coli also acts 
as a virulence factor [54].
Genes involved in biofilm architecture
Three exopolysaccharides, β-1,6-N-acetyl-d-glucosamine 
polymer (PGA) [55], colanic acid a negatively charged 
polymer of glucose, galactose, fucose and glucuronic 
acid and cellulose, have been detected in the biofilm 
matrix of E. coli and considered to be essential for nor-
mal biofilm architecture [56]. Concomitantly, in the pre-
sent study yhjN coding for cellulose synthase regulator 
protein was up regulated where as in ABU strains of E. 
coli genes involved in cellulose synthesis (bcsABZC and 
bcsEFGgenes) were down regulated [43]. Genes encoding 
colanic acid synthesis (wcaL and wcaM) were down regu-
lated in the ocular E. coli and ABU strains [43] probably 
because expression of colanic acid inhibits the biofilm 
ability of E. coli [57]. Further in ocular E. coli L-1216/2010 
colicin protecting conserved protein encoding genes cbrB 
and cbrC are up regulated by 11- and 288-folds respec-
tively compared to the non-biofilm forming cells.
Genes involved in drug transport and active transport
Genes encoding drug transport (mdtM and cycA) and 
aldonate, active transport activity (yjjL, htrE, potGand 
mngA) (Fig.  4a) are differentially regulated in antibiotic 
tolerant ocular E. coli and may thus facilitate drug resist-
ance [47]. In ocular E. coli in the biofilm phase gene emrB 
which confers resistance to cyanide m-chlorophenyl-
hydrazone, tetrachlorosalicylanilide, organomercurials, 
nalidixic acid and thiolactomycin, genes mdlA and mdtM 
which encode multidrug drug efflux pumps [58] and the 
sat gene encoding the secreted auto-transporter toxin 
(Sat) are up regulated. cycA that encodes for glycine, 
serine and alanine transport is predicted to genetically 
interact with gene mdtM and is 47-fold down regulated 
in biofilm forming E. coli cells. cycA mutant strains of 
E. coli are known to exhibit significant resistance for 
d-cycloserine [59]. Thus down regulation of gene cycA 
in biofilm forming E. coli cells significantly contributes 
to antibiotic tolerance. Apart from these efflux pumps, 
ompC encoding secretion of extracellular proteins, gene 
htrE encoding putative chaperone-usher fimbrial protein 
[47] and many genes encoding dehydrogenases (mhpB, 
mhpF, yiaY, yajO/ydbK and yjjN) are up regulated. Gene-
MANIA network analysis of drug and active transport 
genes indicated that all these genes clustered through 
the genetic interaction networks and may facilitate drug 
resistance (Fig. 4a).
Biofilm formation, virulence and other genes
Genes involved in pathogenicity, biofilm formation, 
resistance to antimicrobial compounds and virulence 
are related. Accordingly complete or partial upregula-
tion of 22 genes (c2418 to c2440) in the pathogenicity 
island PAI  IV536 in the UPEC strain 536 and in ABU 
strains VR50 and strain 83972 [43] was observed dur-
ing biofilm formation. In addition, RfaH a virulence 
regulator, which regulates expression of several viru-
lent genes in E. coli is significantly up regulated in ABU 
strains during biofilm phase [43]. None of the above 
genes was differentially regulated in ocular E. coli but 
up regulation of gene ECs3276 a virulence protein pop-
ulating the cluster O80301 [60] was observed (Addi-
tional file 3: Table S2). Apart from this, upregulation of 
several genes encoding for toxin production and secre-
tions (sat, yjgK, chpS, chpB and ygjN) was observed in 
ocular E. coli biofilm cells which is an important factor 
that governs the virulence in pathogenic bacterial cells. 
Virulence of ocular E. coli may also be related to up 
regulation of Lipid A moiety of LPS, a potent stimulator 
of the immune system and a trigger of intense inflam-
mation in the host cells [61]. Many genes encoding for 
proteins that influence antigen presentation (wzzB and 
waaL), extracellular matrix remodeling (yiiX), trans-
port of aminoacids and other metabolites (cbrB, cbrC, 
hisI and mglB) are also up regulated in ocular E. coli in 
biofilm stage and may have a role to play in virulence. 
Costa et al. [61] have recently suggested that in E. coli, 
during biofilm formation on abiotic surfaces, cells are 
exposed to several DNA damaging agents against which 
the cells need to be protected. In the present study gene 
iraD, uvrD and recC involved in DNA damage repair 
are up regulated and could be acting to ensure survival 
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of cells faced with oxidative damage. Thus the viru-
lence presentation in ocular E. coli biofilm cells may be 
an exclusive process. It was also observed that ocular 
E. coli in biofilm phase show up regulation of station-
ary phase response genes (speB, ybeW, hscC and djlC 
which encode for Agmatinase) and genes indicative 
of anaerobic conditions (dsmB, glpB and nrdD). How-
ever the stress response encoding genes up regulated in 
ABU strains of E. coli (such as cspG, cspH, pphA, ibpA, 
ibp, soxS, hha and yfiD) were not up regulated in ocular 
E. coli except uspC encoding a universal stress protein 
which was up regulated [39–41, 43].
Several other genes involved in metabolism, bio-
synthesis, transport, efflux pumps, cell membrane 
structure, DNA replication etc. are also differentially 
regulated in ocular E. coli (Additional file  3: Table S2) 
and may thus be related to biofilm formation, virulence 
or both. Beloin et al. [45] in a review stated that E. coli 
species have not yet revealed all the secrets that contrib-
ute to bacterial biofilm research and one of the reasons 
is attributed to the fact that many of the differentially 
expressed genes were categorized either as unknown or 
coding for hypothetical proteins. In antibiotic resistant 
ocular E. coli also a substantial number of the genes are 
not annotated.
Virulence in E. coli is also known to be associated with 
extrachromosomal elements such as plasmids, associ-
ated bacteriophages and pathogenicity islands [62, 63] 
and a similar up-regulation was observed in ocular bio-
film forming E. coli L-1216/2010 (Additional file 7: Table 
S4). In addition it was observed that other genes such as 
those conferring protection against colicin action (cbrC) 
(Additional file 7: Table S4), ten toxin encoding prophage 
CP-933 related genes (as in Escherichia coli O157:H7 
strain EDL933) [64], phage-related virulence protein 
encoding gene insQ, biofilm modulator toxin encoding 
gene yjgK (Additional file  3: Table S2, Additional file  4: 
Table S3) have also been observed to be up regulated 
Thus it appears that the differential regulation of extra-
chromosomal elements may be implicated in the bio-
film formation and antibiotic resistance in ocular E. coli 
L-1216/2010.
Conclusions
We report the first global gene expression data of anti-
biotic resistant ocular biofilm forming E. coli cells and 
demonstrate that antibiotic tolerance of ocular biofilm 
forming E. coli L-1216/2010 is dependent on up regu-
lation in expression of genes encoding drug transport, 
active transport, multi-drug efflux pumps and genes 
conferring tolerance to drugs. Simultaneously genes 
required for biofilm formation such as genes involved 
adhesion, LPS production and biofilm architecture are 
up regulated. This study also identifies hitherto unre-
ported sets of oxidative stress protecting genes and 
extrachromosomal elements such as plasmids, associ-
ated bacteriophages and pathogenicity islands which are 
also up regulated during biofilm formation in ocular E. 
coli. It is envisaged that inhibition of the above up regu-
lated genes by using inhibitors could serve as a strategy 
for preventing biofilm formation and overcoming drug 
resistance.
In subsequent studies we hope to validate a few of the 
genes for which functions have not been assigned by 
specific gene knock out studies by transposon mediated 
targeted mutagenesis as reported earlier by us [65–67]. 
Inhibition of up regulated genes either by using already 
known inhibitors or by designing new inhibitors would 
also be attempted as an alternative strategy.
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